SKI Market

Indian Indices

Sensex

81,287.19 -961.42
( -1.17%)

Global Indices

Nasdaq

48,844.08 -676.12
(-1.37%)

Dow Jones

6,870.91 -58.95
(-0.85%)

Hang Seng

58,843.60 90.21
(0.15%)

Nikkei 225

10,926.32 79.62
(0.73%)

Forex

USD-INR

90.93 0.01
(0.01%)

EUR-INR

107.33 0.10
(0.10%)

GBP-INR

122.97 -0.01
(-0.01%)

JPY-INR

0.58 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Fermenta Biotech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

506414

INE225B01021

136.8250387

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

13.02

957.54

EPS(TTM)

Face Value()

Div & Yield %

24.98

0.76

Back

Kalyan Capitals consolidated net profit rises 180.95% in the December 2025 quarter

Feb 13,2026

Net profit of Kalyan Capitals rose 180.95% to Rs 0.59 crore in the quarter ended December 2025 as against Rs 0.21 crore during the previous quarter ended December 2024. Sales rose 123.81% to Rs 9.87 crore in the quarter ended December 2025 as against Rs 4.41 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	9.87	4.41	124
OPM %	85.31	91.84	-
PBDT	1.19	-0.10	LP
PBT	1.09	-0.26	LP
NP	0.59	0.21	181

81,287.19 -961.42 ( -1.17%)

48,844.08 -676.12 (-1.37%)

6,870.91 -58.95 (-0.85%)

58,843.60 90.21 (0.15%)

10,926.32 79.62 (0.73%)

90.93 0.01 (0.01%)

107.33 0.10 (0.10%)

122.97 -0.01 (-0.01%)

0.58 0.00 (0.12%)